TYLER HARRELSON: Open Payments
NPI 1417708223 · SAINT CHARLES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 34 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $157 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| ABBVIE INC. | 18 | $167 |
| Lilly USA, LLC | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Novo Nordisk Inc | 1 | $20 |
| TMS NeuroHealth Centers Inc. | 1 | $14 |
Products named: VRAYLAR, FARXIGA, BREZTRI, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO, Rybelsus, JARDIANCE.
Industry payments across MO — which companies pay providers there.
